Skip to search formSkip to main contentSkip to account menu

CP 154526

Known as: CP 154,526, CP-154,526, CP-154526 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyrimidinesPyrroles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
Does amygdaloid corticotropin‐releasing hormone (CRH) mediate anxiety‐like behaviors? Dissociation of anxiogenic effects and CRH release
The brain corticotropin‐releasing hormone (CRH) circuits are activated by stressful stimuli, contributing to behavioral and… 
Highly Cited
2002
Highly Cited
2002
Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat
Highly Cited
2000
Highly Cited
2000
The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats
Abstract. Rationale: Intermittent footshock stress reliably reinstates extinguished alcohol-taking behavior in drug-free rats… 
Highly Cited
2000
Highly Cited
2000
Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.
Corticotropin-releasing factor 1 (CRF(1)) receptor antagonists may represent a novel group of drugs for the pharmacotherapy of… 
Highly Cited
2000
Highly Cited
2000
Peripheral corticotropin-releasing factor and stress-stimulated colonic motor activity involve type 1 receptor in rats.
BACKGROUND & AIMS Corticotropin-releasing factor (CRF) exerts its action through CRF receptors 1 and 2 (CRF-R1 and CRF-R2). CRF… 
Highly Cited
1999
Highly Cited
1999
The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
The nonpeptide CRH antagonist antalarmin has been shown to block both behavioral and endocrine responses to CRH. However, it's… 
Highly Cited
1998
Highly Cited
1998
CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats
Abstract We have found that peptide antagonists of corticotropin-releasing factor (CRF) receptors attenuate reinstatement of… 
Highly Cited
1998
Highly Cited
1998
Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents Comparison with diazepam and buspirone
Abstract The present series of experiments compared the behavioral effects of the novel non-peptide CRF antagonist CP-154,526… 
Highly Cited
1996
Highly Cited
1996
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.
Here we describe the properties of CP-154,526, a potent and selective nonpeptide antagonist of corticotropin (ACTH) releasing… 
Highly Cited
1996
Highly Cited
1996
A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License